Biotronik Magmaris Sirolimus-Eluting Resorbable Coronary Magnesium Scaffold System

Land: Singapur

Sprache: Englisch

Quelle: HSA (Health Sciences Authority)

Verfügbar ab:

BIOTRONIK ASIA PACIFIC PTE. LTD.

Klasse:

Class D (contains therapeutic product or medicinal product)

Hergestellt von:

Biotronik AG

Therapiebereich:

Cardiovascular

Anwendungsgebiete:

is indicated for improving luminal diameter in the treatment of de novo native coronary artery lesions in patients with symptomatic coronary artery disease. The reference vessel diameter should closely match the scaffold nominal diameter. The treated lesion length should be less than the nominal scaffold length.

Produktbesonderheiten:

Device System Info:[Sterile Medical Device], sterile medical device by EO; Models: Magmaris Sirolimus-Eluting Resorbable Coronary Magnesium System - 412526, Magmaris Sirolimus-Eluting Resorbable Coronary Magnesium System - 412529, Magmaris Sirolimus-Eluting Resorbable Coronary Magnesium System - 412527, Magmaris Sirolimus-Eluting Resorbable Coronary Magnesium System - 412530, Magmaris Sirolimus-Eluting Resorbable Coronary Magnesium System - 412528, Magmaris Sirolimus-Eluting Resorbable Coronary Magnesium System - 412531

Berechtigungsdatum:

2018-08-27